Interest in medial aesthetics is at an all-time high according to a new report by global pharmaceutical company Allergan, which questioned individuals about their perceptions of beauty.
A recent poll of 1,033 UK women aged between 18 and 30 has highlighted patient perceptions of non-surgical and surgical cosmetic treatments.
An educational event was hosted by laser developer and manufacturer Cynosure UK on March 21 as part of its Aesthetic Exchange learning and development programme.
Global pharmaceutical company Allergan has manufactured the 100 millionth vial of botulinum toxin type A Botox, which the company has said is a ‘significant milestone in the history of the brand’.
The British College of Aesthetic Medicine (BCAM) has been awarded registered charitable status in England and Wales by the Charity Commission under the Charities Act.
Singapore-based biotech company CellResearch Corporation, the owners of cord-lining stem cell-based cosmeceutical Calecim Professional, has added a fourth product to its portfolio, the Recovery Night Complex.
Aesthetic distributor Merz has launched a dermal filler containing a combination of hyaluronic acid and glycerol called Belotero Revive.
London-based clinic MyBreast Cosmetic Surgery has been chosen as the only UK clinic to participate in an international clinical trial to determine the safety and effectiveness of a number of breast implants including the SmoothSilk, Round and Ergonomix from Motiva Implants.
On March 7, co-owners of Trikwan Aesthetics Dr Zoya Diwan and Dr Sanjay Trikha held the first Academic Aesthetics Mastermind Group at the Royal Society of Medicine (RSM) in London.
A survey conducted by online resource RealSelf found that the top-ranked non-surgical treatment was the diVa vaginal therapy, a laser used to address changes in vaginal health, with a ranking of 100%.